deltatrials
Not Yet Recruiting OBSERVATIONAL NCT03637634

The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study (CANPCSS)

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Conditions NPC Patients
Updated 12 times since 2018 Last updated: Aug 26, 2018 Started: Sep 1, 2018 Primary completion: Dec 31, 2030 Completion: Dec 31, 2035
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03637634, this observational or N/A phase trial focuses on NPC Patients and remains actively recruiting participants. Sponsored by Affiliated Cancer Hospital & Institute of Guangzhou Medical University, it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2018 – ~Nov 2020 · 26 months · monthly snapshotNot Yet Recruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotNot Yet Recruiting~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotNot Yet Recruiting~Dec 2021 – ~Nov 2022 · 11 months · monthly snapshotNot Yet Recruiting~Nov 2022 – ~Jul 2023 · 8 months · monthly snapshotNot Yet Recruiting~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotNot Yet Recruiting~Jun 2025 – ~Aug 2025 · 2 months · monthly snapshotNot Yet Recruiting~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshotNot Yet Recruiting~Sep 2025 – present · 10 months · monthly snapshotNot Yet Recruiting

Change History

12 versions recorded
  1. Sep 2025 — Present [monthly]

    Not Yet Recruiting

  2. Aug 2025 — Sep 2025 [monthly]

    Not Yet Recruiting

  3. Jun 2025 — Aug 2025 [monthly]

    Not Yet Recruiting

  4. Sep 2024 — Jun 2025 [monthly]

    Not Yet Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

Show 7 earlier versions
  1. Jul 2023 — Jul 2024 [monthly]

    Not Yet Recruiting

  2. Nov 2022 — Jul 2023 [monthly]

    Not Yet Recruiting

  3. Dec 2021 — Nov 2022 [monthly]

    Not Yet Recruiting

  4. Oct 2021 — Dec 2021 [monthly]

    Not Yet Recruiting

  5. Jan 2021 — Oct 2021 [monthly]

    Not Yet Recruiting

  6. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting

  7. Sep 2018 — Nov 2020 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University
  • Affiliated Cancer Hospital of Shantou University Medical College
  • Cancer Hospital of Guangxi Medical University
  • Cancer Hospital of Guizhou Province
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences
  • Dongguan People's Hospital
  • Fifth Affiliated Hospital, Sun Yat-Sen University
  • First Affiliated Hospital of Jinan University
  • First People's Hospital of Foshan
  • Fudan University
  • Fujian Cancer Hospital
  • Guangdong Provincial People's Hospital
  • Hai-Qiang Mai,MD,PhD
  • Hunan Cancer Hospital
  • Jiangmen Central Hospital
  • Jiangsu Cancer Institute & Hospital
  • Jiangxi Provincial Cancer Hospital
  • Nanfang Hospital, Southern Medical University
  • Peking University Cancer Hospital & Institute
  • Second Affiliated Hospital of Nanchang University
  • Shandong Cancer Hospital and Institute
  • Shenzhen Second People's Hospital
  • Sichuan Cancer Hospital and Research Institute
  • The First Affiliated Hospital of Zhengzhou University
  • Tongji Hospital
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • Yuebei People's Hospital
  • Zhanjiang Cancer Hospital
  • Zhejiang Cancer Hospital
  • Zhongnan Hospital
Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.